Is tonix Pharmaceuticals a good stock to buy?
Tonix Pharmaceuticals has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.
Why was tonix stock so high?
What happened. A big regulatory win was reaping huge prizes for Tonix Pharmaceuticals ( TNXP 0.17% ) on Thursday. Following a new nod from the Food and Drug Administration (FDA) for one of its leading pipeline drugs, the biotech's shares went on a quick trip skyward, rising 33% in price on the day.Mar 3, 2022
What is the future of TNXP?
On average, analysts forecast that TNXP's EPS will be -$0.20 for 2022, with the lowest EPS forecast at -$0.20, and the highest EPS forecast at -$0.20. On average, analysts forecast that TNXP's EPS will be -$0.20 for 2023, with the lowest EPS forecast at -$0.20, and the highest EPS forecast at -$0.20.
Did TNXP reverse split?
31, 2019 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, announced today that it will effect a 1-for-10 reverse stock split of its outstanding common stock.Oct 31, 2019
Where is tonix Pharmaceuticals located?
Chatham, New jerseyTonix Pharmaceuticals (Tonix Pharmaceuticals Holding Corp.) is a pharmaceutical company based in Chatham, New jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project.
Why did TNXP drop so much?
The big decline came after Tonix announced on Friday following the market close that it is halting enrollment in a late-stage clinical study evaluating TNX-102 SL in treating fibromyalgia.Jul 26, 2021
Will TXMD stock go up?
and has now fallen 5 days in a row. During the day the stock fluctuated 8.91% from a day low at $0.25 to a day high of $0.28....Predicted Opening Price for TherapeuticsMD Inc of Thursday, April 21, 2022.Fair opening price April 21, 2022Current price$0.26$0.26 (Undervalued)
Will Biol stock go up?
During the day the stock fluctuated 10.00% from a day low at $0.30 to a day high of $0.33. The price has fallen in 6 of the last 10 days and is down by -7.88% for this period....Predicted Opening Price for Biolase of Tuesday, April 19, 2022.Fair opening price April 19, 2022Current price$0.32$0.33 (Overvalued)
Brittany Meiling
After scoring two promising FDA designations on its lead drug, tiny Tonix Pharmaceuticals is aborting its late-stage study in PTSD due to lousy results — nearly flat-lining the company’s stock Friday morning.
Luca Issi
Genetic medicine, the delivery of genetic material as a therapeutic, has attracted record-breaking capital in biotech with ~$150 billion invested across ventures, IPOs, follow-ons, and M&A since 2013.
Amber Tong
Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add Endpoints Weekly. New to Endpoints? Sign up here.
Kyle Blankenship
Looking to scuffle with rare disease giant and now AstraZeneca subsidiary Alexion, little Apellis scored a breakthrough win earlier this summer for its own complement factor inhibitor drug. Apellis, though, always had its eyes on bigger fish, but a first glimpse at pivotal data for a major indication has muddied the waters.
Premium subscription required
Unlock this article along with other benefits by subscribing to one of our paid plans.
Zachary Brennan
Overshadowed by President Biden’s vaccine mandate announcement, the administration earlier in the day released its top priorities for drug pricing reforms making their way through Congress.
John Carroll
One of Paul Hudson’s picks for Sanofi’s pipeline has gone down in defeat in a Phase III trial.
1 TNXP Stock's Price Graph & Average Annual Return
Below is a graph showing closing prices of Tonix Pharmaceuticals Holding Corp (TNXP) for the past 10 years. The below chart uses adjusted close instead of market close prices. (Adjusted close factors in corporate or institutional level actions outside the market.)
2 How Tonix Pharmaceuticals Holding Corp (TNXP) Stock Performed Against The Entire Stock Market
You should not evaluate a stock in isolation. Rather, you will benefit more if you assess the performance against broad indices and similar stocks.
4 10 Biggest One-Day Losses
Let us now see 10 biggest one-day losses of Tonix Pharmaceuticals Holding Corp (TNXP) stock.
Conclusion
Hopefully, the above report helps you learn about the past ten-year performance of Tonix Pharmaceuticals Holding Corp (TNXP) shares. Kindly use the sections below to suggest corrections or improvements to the report.
Want to become a smart investor?
Netcials reports section helps you with deep insights into the performance of various assets over the years. We are constantly upgrading and updating our reports section. Feel free to access them. Do not forget to leave your feedback.
Where is Tonix Pharmaceuticals located?
Tonix Pharmaceuticals is based in New York and specializes in producing drugs that treat specific central nervous system conditions. “These results underscore the challenges in designing and conducting well-controlled clinical studies in PTSD, especially military-related PTSD.
Is Tonix a Phase 2 drug?
In addition to its Tonmya drug, Tonix is currently working on a bedtime treatment drug for agitation in Alz heimer’s disease, which is currently in its Phase 2 of its trial.
Is Tonix halting Phase 3?
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP) announced this morning that it would be halting its Phase 3 study of its Tonmya drug, which caused its stock price to drop in dramatic fashion.
Recently Viewed Tickers
Visit a quote page and your recently viewed tickers will be displayed here.
Tonix Pharmaceuticals Holding Corp
Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800.
